Executive Order 13890: Protecting and Improving Medicare for Our Nation's Seniors

President: Donald J. Trump

Directed HHS to review Medicare policies on choice, telehealth, site-neutral payments and private plans. Individual payment rules required their own rulemaking.

Status: In effect. Sources: Official source.

Is Executive Order 13890 still in effect? Yes. Executive Order 13890 of October 3, 2019 remains unrevoked. Its Medicare directions include annual proposals to combat fraud, waste, and abuse under section 9. Repeal of a particular implementing rule did not revoke the executive order.

What does Executive Order 13890 do?

EO 13890 instructed HHS to review Medicare rules and guidance, strengthen beneficiary protections and consider changes to private-plan and supplemental coverage within existing law.

Later evidence reviewed September 24, 2026: CMS repealed its earlier Medicare Coverage of Innovative Technology rule after having issued it in response to EO 13890. The repeal concerns that rule, not every Medicare initiative mentioned in the order. CMS repeal of MCIT rule.

Administration position: The stated directions and policy are summarized from the signed order. See the official text for its precise legal terms.
SignedOctober 3, 2019
IssuerPresident Donald J. Trump
TermFirst presidential term

Before and after

Before the order

Medicare benefits and payment models operated under statutes and CMS rules.

After the order

CMS repealed its earlier Medicare Coverage of Innovative Technology rule after having issued it in response to EO 13890. The repeal concerns that rule, not every Medicare initiative mentioned in the order.

Who had to do what

Agency / officialWhat the signed order directedDeadline / timing
Secretary of Health and Human ServicesImplement the market-based Medicare recommendations identified in the EO 13813 healthcare report. Propose rules and administrative changes for diverse Medicare plans, innovative Medicare Advantage benefits, rebates and neutrality between FFS and MA; revise network adequacy; reduce billing/licensure/supervision burdens and review clinician reimbursement disparities; streamline FDA–CMS coverage/coding and parallel review and adjust the Value-Based Insurance Design model; support site competition; provide quality/cost data and risky-practice information; reduce provider inefficiencies and private-contract barriers. Recommend market-based FFS pricing, including MA/commercial comparisons, competitive bidding, savings and information sharing. Combat fraud using regulatory/subregulatory changes and appropriate resources; revise enrollment rules to preserve Social Security benefits for those declining Part A.Most rule proposals/actions within one year of October 3, 2019. Pricing reports/study recommendations and Part A/Social Security revisions within 180 days. Anti-fraud changes to take effect by January 1, 2021, with annual proposals thereafter; no separate date for site competition/resource deployment.
Council of Economic Advisers ChairmanConsult HHS on the report comparing FFS payment with MA and commercial prices to promote competition.Report within 180 days of October 3, 2019, through Domestic and Economic Policy assistants.
Commissioner of Social SecurityCoordinate with HHS on rules preserving retirement-insurance benefits for seniors declining Medicare Part A.Within 180 days of October 3, 2019.

Source: Signed Federal Register text.

What happened next

EO 13890 signed; its Federal Register publication followed.